Oct 27 (Reuters) - Organon (OGN.N), opens new tab said on Monday CEO Kevin Ali will resign from his role, after an internal investigation into sales of its Nexplanon contraceptive implant to ...

Organon announced significant leadership changes Oct. 27 as part of its response to an internal investigation into improper sales practices related to its Nexplanon product. Ali The company’s board of ...

Researchers from Seoul National University (Prof. Seung-Kyun Kang), the Korea Institute of Science and Technology, KIST (Dr. Hyojin Lee), Kwangwoon University (Prof. Jeonghyun Kim), and Gyeongsang ...

The body horror videos detailed severe striated bruising at the site of the implant that escalated to visible light flashing from the device beneath Rubes’s skin, which went viral on TikTok. Rubes’s ...

Long-acting reversible contraception (LARC) is widely regarded as a transformative advancement in reproductive healthcare. Offering unparalleled efficacy and ease of use, LARC methods such as ...

With massive social media hype around its intricate world-building and steamy love scenes, perhaps no literary genre has made quite as big of a splash in recent years as the fantasy-romance segment, ...

CEO Kevin Ali stated that Q1 2025 results met expectations, with Nexplanon achieving double-digit growth and projected to exceed $1 billion in revenue for the year. He highlighted the success of the ...

Anytime you try a new supplement, it’s important to have the right information so you’ll know about possible side effects. That’s true, too, for cannabidiol, also known as CBD. There are many CBD ...

ABSTRACT: Introduction: Family planning is one of the pillars of the Safe Motherhood Initiative which is aimed at reducing unwanted pregnancy and maternal death. Objective: To evaluate the uptake, ...

ABSTRACT: Introduction: Family planning is one of the pillars of the Safe Motherhood Initiative which is aimed at reducing unwanted pregnancy and maternal death. Objective: To evaluate the uptake, ...

Full-year 2025 revenue guidance is set between $6.125 billion to $6.325 billion. Kevin Ali stated, "On a constant currency basis, the midpoint of this range would reflect flat revenue performance," ...

Silo Pharma, Inc. announced encouraging preliminary results from an ongoing study of its SP-26 ketamine extended-release rods, which are being evaluated for safety and pharmacokinetics after being ...